logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Nebraska Cancer Specialists: CHI Henry Lynch Cancer Center

+14023344773
events@nebraskacancer.com
Source: Site record.
https://nebraskacancer.com

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Nebraska Cancer Specialists (NCS) is a community oncology practice in Nebraska, USA, with an extensive clinical research program offering trials from early phase through Phase IV. The practice conducts clinical trials across a broad range of cancer types, including breast, colorectal, lung, prostate, pancreatic, kidney, and hematological cancers. Its research focuses on evaluating investigational drugs, targeted therapies, immunotherapies, and precision medicine approaches to improve cancer treatment outcomes. Supported by experienced oncologists and a dedicated research team, NCS facilitates patient screening and enrollment, clinical trial coordination, and safety monitoring, collaborating with research partners to advance cancer care and provide patients with access to emerging treatment options

Business Status

Source: Google. OPEN

Business Category

Source: Google. Cancer treatment center

Business Subcategory

Source: Google. Cancer treatment center
Source: Google. Hematologist
Source: Google. Medical clinic
Source: Google. Oncologist
Source: Trial-derived.
117Total Trials
Source: Trial-derived.
24Recruiting Trials
Source: Trial-derived.
78Active Trials
Source: Trial-derived.
25Completed Trials
Source: Trial-derived.
591Unique Conditions
Source: Trial-derived.
38Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Breast Cancer (8)Source: Trial-derived. Prostate Cancer (4)Source: Trial-derived. Recurrent Melanoma (4)Source: Trial-derived. Stage IIIB Lung Cancer AJCC v8 (4)Source: Trial-derived. Stage IV Cutaneous Melanoma AJCC v6 and v7 (4)Source: Trial-derived. Chronic Lymphocytic Leukemia (3)Source: Trial-derived. Clinical Stage III Cutaneous Melanoma AJCC v8 (3)Source: Trial-derived. Clinical Stage IV Cutaneous Melanoma AJCC v8 (3)

Sponsors

Source: Trial-derived. National Cancer Institute (NCI) (83)Source: Trial-derived. NRG Oncology (14)Source: Trial-derived. Alliance for Clinical Trials in Oncology (13)Source: Trial-derived. SWOG Cancer Research Network (10)Source: Trial-derived. Novartis Pharmaceuticals (8)Source: Trial-derived. ECOG-ACRIN Cancer Research Group (6)Source: Trial-derived. BeOne Medicines (4)Source: Trial-derived. Canadian Cancer Trials Group (4)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. CT Scan
Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI
Source: AI-inferred. Echocardiography
Source: AI-inferred. PET-CT
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. Full pulmonary function lab (DLCO / plethysmography)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Biobanking
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. Circulating tumour DNA testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Intensity-modulated radiation therapy
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Endoscopy / colonoscopy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. CD4 lymphocyte enumeration
Source: AI-inferred. HIV viral-load testing
Source: AI-inferred. Tumour response imaging (modality not specified)
Source: AI-inferred. ALK rearrangement testing
Source: AI-inferred. Behavioral health or psychiatric support
Source: AI-inferred. CD4 T-cell enumeration
Source: AI-inferred. Clinical cytopathology
Source: AI-inferred. Diagnostic radiologic imaging